b2venture
Founder-network VC with DACH bias; tags healthcare, biotech and medical, incl. preventative health.
- Based in
- St. Gallen, Switzerland
- Type
- VC
- Stage
- Pre-seed, Seed, Series A
- Cheque size
- €250k-€5m (average about €1m)
- Backs
- Fitness & movement, Sleep, recovery & longevity, Care & clinical
- Business models
- Consumer app or subscription, Consumer product, Physical sites
- Recent deal
- Amplifold (DNA-origami rapid diagnostic tests) seed, 2025; portfolio company Everlab raised AUD 65m Series A, June 2026 (b2venture role not stated)
Also backed
- EverlabPreventative health and diagnostics clinic
- NellyDigital medical practice workflow and payments
- Urban Sports ClubFitness and wellbeing membership
Get the full investor map.
Every finder match and founder checklist, plus an Excel download. Free with Healthier Notes.
Unlock the map